ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Diabetes on the Newborn

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00831519
Recruitment Status : Completed
First Posted : January 29, 2009
Last Update Posted : November 30, 2017
Sponsor:
Information provided by (Responsible Party):
Prof. Jacob Bornstein, Western Galilee Hospital-Nahariya

Brief Summary:
The aim of this study is to test and compare biochemical, hematological, and inflammatory factors in diabetic and healthy pregnant mothers and in their newborns.

Condition or disease
Diabetes

Study Type : Observational
Actual Enrollment : 40 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: Biochemical, Hematologic, and Inflammatory Effects of Diabetes on the Newborn
Study Start Date : January 2009
Actual Primary Completion Date : February 2015
Actual Study Completion Date : December 2015

Group/Cohort
Macrosomial, GD
Macrosomial, control



Primary Outcome Measures :
  1. oxidative stress [ Time Frame: Immediately after delivery by cesarean section ]
    New borns of diabetic mother may have oxidative stress



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Pregnant women who plan to deliver at Western Galilee Hospital
Criteria

Inclusion Criteria:

  • pregnant women

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00831519


Locations
Israel
Western Galilee Hospital- Nahariya
Nahariya, Israel
Sponsors and Collaborators
Western Galilee Hospital-Nahariya

Responsible Party: Prof. Jacob Bornstein, Principal Investigator, Western Galilee Hospital-Nahariya
ClinicalTrials.gov Identifier: NCT00831519     History of Changes
Other Study ID Numbers: JB_6.08_1
First Posted: January 29, 2009    Key Record Dates
Last Update Posted: November 30, 2017
Last Verified: November 2017

Additional relevant MeSH terms:
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases